1. Home
  2. DIN vs KMDA Comparison

DIN vs KMDA Comparison

Compare DIN & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dine Brands Global Inc.

DIN

Dine Brands Global Inc.

N/A

Current Price

$30.50

Market Cap

446.6M

ML Signal

N/A

Logo Kamada Ltd.

KMDA

Kamada Ltd.

N/A

Current Price

$8.92

Market Cap

458.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DIN
KMDA
Founded
1958
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
446.6M
458.6M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
DIN
KMDA
Price
$30.50
$8.92
Analyst Decision
Hold
Strong Buy
Analyst Count
6
3
Target Price
$29.67
$13.00
AVG Volume (30 Days)
392.7K
66.6K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
2.41%
2.26%
EPS Growth
N/A
N/A
EPS
1.11
N/A
Revenue
$879,300,000.00
N/A
Revenue This Year
$3.61
$14.79
Revenue Next Year
$0.41
$11.38
P/E Ratio
$28.35
$24.59
Revenue Growth
8.25
N/A
52 Week Low
$18.63
$5.54
52 Week High
$39.68
$9.35

Technical Indicators

Market Signals
Indicator
DIN
KMDA
Relative Strength Index (RSI) 39.87 57.85
Support Level $23.19 $6.69
Resistance Level $35.76 $9.35
Average True Range (ATR) 1.62 0.27
MACD -0.01 -0.02
Stochastic Oscillator 44.05 72.63

Price Performance

Historical Comparison
DIN
KMDA

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: